Long‐term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy

To assess the long‐term outcome of catheter ablation in patients with hypertrophic cardiomyopathy (HCM), especially in patients with apical HCM (ApHCM).

[1]  J. Uhm,et al.  Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy , 2017, Heart.

[2]  A. Tajik,et al.  Apical hypertrophic cardiomyopathy: Present status. , 2016, International journal of cardiology.

[3]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  R. Omar,et al.  Predictors of atrial fibrillation in hypertrophic cardiomyopathy , 2016, Heart.

[5]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[6]  Young-Hoon Kim,et al.  Long‐Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy , 2016, Journal of cardiovascular electrophysiology.

[7]  H. Tse,et al.  Prospective randomized comparison between a fixed '2C3L' approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  R. Omar,et al.  Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA) , 2015, European journal of heart failure.

[9]  F. Rutten,et al.  [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.

[10]  Barry J Maron,et al.  Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. , 2014, Journal of the American College of Cardiology.

[11]  G. Fu,et al.  Incidence of pulmonary vein conduction recovery in patients without clinical recurrence after ablation of paroxysmal atrial fibrillation: mechanistic implications. , 2014, Heart rhythm.

[12]  Dhanunjaya R. Lakkireddy,et al.  Catheter Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Long-Term Outcomes and Mechanisms of Arrhythmia Recurrence , 2013, Circulation. Arrhythmia and electrophysiology.

[13]  P. Elliott,et al.  Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review , 2013, Heart.

[14]  D. Packer,et al.  Long‐Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence , 2010, Journal of cardiovascular electrophysiology.

[15]  F. Carreras,et al.  Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study. , 2010, European journal of radiology.

[16]  Michel Haissaguerre,et al.  Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  S. Ommen,et al.  Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy , 2008, Journal of cardiovascular electrophysiology.

[18]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[19]  M. Allessie,et al.  Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. , 1997, Circulation.

[20]  C. Tei,et al.  Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. , 1976, Japanese heart journal.

[21]  P. Lambiase,et al.  Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis , 2016, Heart.